Glycan Therapeutics Corporation

Biotechnology company · Raleigh, North Carolina, United States

Glycan Therapeutics Corporation is a biotechnology company headquartered in Raleigh, North Carolina, United States. It has received 23 US government small-business research awards (SBIR/STTR) from health agencies, $25 million in total, most recently in 2024.

glycantherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Glycan Therapeutics at a glance

Typebiotechnology company

HeadquartersRaleigh, North Carolina, United States

Employees (self-reported, 2024)10

What does Glycan Therapeutics do?

US government research funding

23 SBIR/STTR small-business research awards from US health agencies, $24.8 million in total (2013 to 2024). NIH funding came from the National Institute of General Medical Sciences, National Heart, Lung, and Blood Institute, National Cancer Institute.

Frequently asked questions about Glycan Therapeutics

Where is Glycan Therapeutics headquartered?

Glycan Therapeutics Corporation is headquartered in Raleigh, North Carolina, United States.

What does Glycan Therapeutics do?

Glycan Therapeutics Corporation is a biotechnology company.

Similar companies

Arrevus, Inc.Raleigh, North Carolina, United States
NuPulseCV, Inc.Raleigh, North Carolina, United States
GeneVentiv Therapeutics, Inc.Raleigh, North Carolina, United States
RainBio, Inc.Raleigh, North Carolina, United States
Aer Therapeutics, Inc.Raleigh, North Carolina, United States
Merz Pharmaceuticals, LLCRaleigh, North Carolina, United States
Tribofilm Research IncRaleigh, North Carolina, United States
Bedrock Therapeutics, Inc.Raleigh, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences